{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:21:59Z","timestamp":1780453319684,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["Grant ID 120380763212 \u2013 PPTA # 835"],"award-info":[{"award-number":["Grant ID 120380763212 \u2013 PPTA # 835"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41434-019-0086-3","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T10:02:56Z","timestamp":1562061776000},"page":"104-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6484-1173","authenticated-orcid":false,"given":"Carlos J.","family":"Alm\u00e9ciga-Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"86_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","volume":"13","author":"RJ Desnick","year":"2012","unstructured":"Desnick RJ, Schuchman EH. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet. 2012;13:307\u201335.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"86_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0879-2","volume":"13","author":"OY Echeverri","year":"2018","unstructured":"Echeverri OY, Guevara JM, Espejo-Mojica \u00c1J, Ardila A, Pulido N, Reyes M, et al. Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years\u2019 experience from a reference center. Orphanet J Rare Dis. 2018;13:141.","journal-title":"Orphanet J Rare Dis"},{"key":"86_CR3","first-page":"160","volume":"25","author":"L Barrera","year":"2002","unstructured":"Barrera L, Gutierrez M, Ceron F, Garcia L. Evaluation of an episomal expression construct containing the cDNA of iduronate sulfatase in (IDS) in fibroblasts from a patient with hunter syndrome. J Inherit Metab Dis. 2002;25:160.","journal-title":"J Inherit Metab Dis"},{"key":"86_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7705\/biomedica.v32i4.574","volume":"32","author":"AM G\u00f3mez","year":"2012","unstructured":"G\u00f3mez AM, Garc\u00eda-Robles R, Su\u00e1rez-Obando F. Estimaci\u00f3n de las frecuencias de las mucopolisacaridosis y an\u00e1lisis de agrupamiento espacial en los departamentos de Cundinamarca y Boyac\u00e1. Biom\u00e9dica. 2012;32:602\u20139.","journal-title":"Biom\u00e9dica"},{"key":"86_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/TACG.S141881","volume":"11","author":"SM Tapiero-Rodriguez","year":"2018","unstructured":"Tapiero-Rodriguez SM, Acosta Guio JC, Porras-Hurtado GL, Garc\u00eda N, Solano M, Pachajoa H, et al. Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA. Appl Clin Genet. 2018;11:45\u201357.","journal-title":"Appl Clin Genet"},{"key":"86_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ymgmr.2018.06.008","volume":"16","author":"LJ Moreno Giraldo","year":"2018","unstructured":"Moreno Giraldo LJ, Escudero Rodr\u00edguez \u00c1M, S\u00e1nchez G\u00f3mez A, Satizabal Soto JM. Clinical and molecular characteristics of colombian patients with mucopolysaccharidosis IVA, and description of a new galns gene mutation. Mol Genet Metab Rep. 2018;16:53\u201356.","journal-title":"Mol Genet Metab Rep"},{"key":"86_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0173-x","volume":"9","author":"RM Leadley","year":"2014","unstructured":"Leadley RM, Lang S, Misso K, Bekkering T, Ross J, Akiyama T, et al. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis. 2014;9:173.","journal-title":"Orphanet J Rare Dis"},{"key":"86_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1399-0004.2006.00670.x","volume":"70","author":"JE Bernal","year":"2006","unstructured":"Bernal JE, Briceno I. Genetic and other diseases in the pottery of Tumaco-La Tolita culture in Colombia\u2013Ecuador. Clin Genet. 2006;70:188\u201391.","journal-title":"Clin Genet"},{"key":"86_CR9","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1111\/j.1742-4658.2010.07769.x","volume":"277","author":"CJ Alm\u00e9ciga-D\u00edaz","year":"2010","unstructured":"Alm\u00e9ciga-D\u00edaz CJ, Monta\u00f1o AM, Tomatsu S, Barrera LA. Adeno-associated virus gene transfer in Morquio A disease-effect of promoters and sulfatase-modifying factor 1. FEBS J. 2010;277:3608\u201319.","journal-title":"FEBS J"},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s11033-008-9392-3","volume":"36","author":"CJ Alm\u00e9ciga-D\u00edaz","year":"2009","unstructured":"Alm\u00e9ciga-D\u00edaz CJ, Rueda-Paramo MA, Espejo AJ, Echeverri OY, Monta\u00f1o A, Tomatsu S, et al. Effect of elongation factor 1\u03b1 promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase. Mol Biol Rep. 2009;36:1863\u201370.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"86_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41390-018-0095-8","volume":"84","author":"Carlos J. Alm\u00e9ciga-D\u00edaz","year":"2018","unstructured":"Alm\u00e9ciga-D\u00edaz CJ, Monta\u00f1o AM, Barrera LA, Tomatsu S. Tailoring the AAV2 capsid vector for bone-targeting. Pediatr Res. 2018;84:545\u2013551.","journal-title":"Pediatric Research"},{"key":"86_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymgme.2015.08.001","volume":"117","author":"DA Salazar","year":"2016","unstructured":"Salazar DA, Rodr\u00edguez-L\u00f3pez A, Herre\u00f1o A, Barbosa H, Herrera J, Ardila A, et al. Systems biology study of mucopolysaccharidosis using a human metabolic reconstruction network. Mol Genet Metab. 2016;117:129\u201339.","journal-title":"Mol Genet Metab"},{"key":"86_CR13","first-page":"1","volume":"0","author":"CR Ferreira","year":"2018","unstructured":"Ferreira CR, van Karnebeek CDMM, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med. 2018;0:1\u20135.","journal-title":"Genet Med"},{"key":"86_CR14","doi-asserted-by":"publisher","unstructured":"Docquier F. The brain drain from developing countries. IZA World Labor. 2014:31. \nhttps:\/\/doi.org\/10.15185\/izawol.31\n\n.","DOI":"10.15185\/izawol.31"},{"key":"86_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1542\/peds.2009-3246","volume":"126","author":"SS Talele","year":"2010","unstructured":"Talele SS, Xu K, Pariser AR, Braun MM, Farag-El-Massah S, Phillips MI, et al. Therapies for inborn errors of metabolism: what has the Orphan Drug Act delivered? Pediatrics. 2010;126:101\u20136.","journal-title":"Pediatrics"},{"key":"86_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1590\/S1415-47572014000200015","volume":"37","author":"R Linden","year":"2014","unstructured":"Linden R, Matte U. A snapshot of gene therapy in Latin America. Genet Mol Biol. 2014;37:294\u20138.","journal-title":"Genet Mol Biol"},{"key":"86_CR17","doi-asserted-by":"publisher","first-page":"e0140002","DOI":"10.1371\/journal.pone.0140002","volume":"10","author":"T Gammie","year":"2015","unstructured":"Gammie T, Lu CY, Babar ZU-D. Access to orphan drugs: a comprehensive review of legislations, regulations and policies in 35 countries. PLoS ONE. 2015;10:e0140002.","journal-title":"PLoS ONE"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0086-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:02Z","timestamp":1684617242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-019-0086-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":17,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1038\/s41434-019-0086-3","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare to be part of the patent: Delivery of Therapeutic Agents to the Bone.\u00a0\u00a0 Patent No.: US 7,972,593 B2; date July 5, 2011, patent that is not generating royalties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}